Trials / Completed
CompletedNCT01917110
Efficacy and Safety of MiSight ® Contact Lenses in Reducing the Progression of Childhood Myopia.
Efficacy and Safety of MiSight ® Contact Lenses in Reducing the Progression of Childhood Myopia, Not Pathological, Aged 8-12 Years Randomized Clinical Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- CooperVision, Inc. · Industry
- Sex
- All
- Age
- 8 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to quantify the effectiveness of CooperVision MiSight® (omafilcon A) soft (hydrophilic) contact lens in slowing the rate of progression of juvenile-onset myopia.
Detailed description
Subjects in two parallel groups were randomized and assigned to either the study contact lens (omafilcon a) or single vision spectacles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | omafilcon A | |
| DEVICE | Spectacle |
Timeline
- Start date
- 2013-09-13
- Primary completion
- 2016-06-16
- Completion
- 2016-06-16
- First posted
- 2013-08-06
- Last updated
- 2020-08-03
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01917110. Inclusion in this directory is not an endorsement.